-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, with the aging of the population and the widespread use of mobile phones and computers, more and more people are suffering from eye problems
.
According to data from the National Health and Medical Commission, in 2018, the number of outpatient visits in ophthalmology specialist hospitals in China was nearly 30 million, an increase of more than 2 times that of 10 years ago
.
In this context, in order to further improve the people's eye health level and continue to promote the high-quality development of China's eye health cause, the state has begun to issue a series of documents to promote the development of China's eye health work
.
During this period, the market of China's ophthalmology hospitals has expanded rapidly and has grown to 100 billion yuan.
The eye health service is a blue ocean of trillions of dollars, and all kinds of ophthalmology service institutions have blossomed, and a large number of enterprises have ushered in development opportunities
.
It is understood that today He's Ophthalmology officially landed on the Growth Enterprise Market, becoming the second ophthalmic medical service institution on the A-share market
.
According to the data, as a group-type chain medical institution that provides ophthalmology specialist diagnosis and treatment services and optometry services for eye disease patients, He's Ophthalmology integrates medicine, teaching and research, adopts a three-level eye health medical service model, and is committed to the whole life cycle of eye health.
management
.
At present, its diagnosis and treatment services include cataract, glaucoma, vitreoretinopathy and other common blinding eye diseases, as well as dry eye, traditional Chinese medicine and other special diagnosis and treatment services; at the same time, it provides optical correction, refractive error surgery and visual function training for refractive errors and other ophthalmology specialist diagnosis and treatment services and optometry services
.
In addition, the company has rich experience in the diagnosis and treatment of common and complex and difficult infant eye diseases, and has a laboratory engaged in the research and development of hereditary eye diseases.
He has accumulated rich experience in genetic diagnosis of blindness
.
It is worth mentioning that after years of practice and in-depth cultivation of ophthalmology specialist diagnosis and treatment services and optometry services, while Ho's Ophthalmology has rich clinical diagnosis and treatment experience and professional technical advantages, its market has begun to expand and its income has also increased.
Continued development trend
.
From 2018 to 2020, the company's operating income was 614 million yuan, 746 million yuan, and 838 million yuan, respectively, and the net profit was 56.
1 million yuan, 80.
6 million yuan, and 100 million yuan, respectively, showing a significant growth trend.
.
As the development momentum continues to improve, the industry is very optimistic about it.
After the opening of the market, the stock price has shown an upward trend, at 51.
00 yuan per share.
As of 11:00, its stock price was 51.
88 yuan, up 22.
07%
.
Ho's Ophthalmology said that the company will take this listing as an opportunity to continue to consolidate its dominant position in the field of eye health management
.
The funds raised from this listing will be mainly used for the expansion of Shenyang He's Hospital, the new He's Eye Hospital in Beijing, the new He's Eye Hospital in Chongqing, the new optometry center of He's Eye and the information construction of He's Eye.
Further improve the business layout, increase the company's market share and industry influence, improve and enhance the company's information management level, and ensure the sustainable and rapid development of the company's business
.
In this regard, the industry believes that in the future, with the professional medical technical team, medical service ability and level, medical quality status, scientific research and teaching and other comprehensive capabilities, He's Ophthalmology is expected to replicate the tertiary eye health medical service model and expand its business to Nationwide, further enhance the company's market competitiveness and achieve leapfrog development of the company
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
.
According to data from the National Health and Medical Commission, in 2018, the number of outpatient visits in ophthalmology specialist hospitals in China was nearly 30 million, an increase of more than 2 times that of 10 years ago
.
In this context, in order to further improve the people's eye health level and continue to promote the high-quality development of China's eye health cause, the state has begun to issue a series of documents to promote the development of China's eye health work
.
During this period, the market of China's ophthalmology hospitals has expanded rapidly and has grown to 100 billion yuan.
The eye health service is a blue ocean of trillions of dollars, and all kinds of ophthalmology service institutions have blossomed, and a large number of enterprises have ushered in development opportunities
.
It is understood that today He's Ophthalmology officially landed on the Growth Enterprise Market, becoming the second ophthalmic medical service institution on the A-share market
.
According to the data, as a group-type chain medical institution that provides ophthalmology specialist diagnosis and treatment services and optometry services for eye disease patients, He's Ophthalmology integrates medicine, teaching and research, adopts a three-level eye health medical service model, and is committed to the whole life cycle of eye health.
management
.
At present, its diagnosis and treatment services include cataract, glaucoma, vitreoretinopathy and other common blinding eye diseases, as well as dry eye, traditional Chinese medicine and other special diagnosis and treatment services; at the same time, it provides optical correction, refractive error surgery and visual function training for refractive errors and other ophthalmology specialist diagnosis and treatment services and optometry services
.
In addition, the company has rich experience in the diagnosis and treatment of common and complex and difficult infant eye diseases, and has a laboratory engaged in the research and development of hereditary eye diseases.
He has accumulated rich experience in genetic diagnosis of blindness
.
It is worth mentioning that after years of practice and in-depth cultivation of ophthalmology specialist diagnosis and treatment services and optometry services, while Ho's Ophthalmology has rich clinical diagnosis and treatment experience and professional technical advantages, its market has begun to expand and its income has also increased.
Continued development trend
.
From 2018 to 2020, the company's operating income was 614 million yuan, 746 million yuan, and 838 million yuan, respectively, and the net profit was 56.
1 million yuan, 80.
6 million yuan, and 100 million yuan, respectively, showing a significant growth trend.
.
As the development momentum continues to improve, the industry is very optimistic about it.
After the opening of the market, the stock price has shown an upward trend, at 51.
00 yuan per share.
As of 11:00, its stock price was 51.
88 yuan, up 22.
07%
.
Ho's Ophthalmology said that the company will take this listing as an opportunity to continue to consolidate its dominant position in the field of eye health management
.
The funds raised from this listing will be mainly used for the expansion of Shenyang He's Hospital, the new He's Eye Hospital in Beijing, the new He's Eye Hospital in Chongqing, the new optometry center of He's Eye and the information construction of He's Eye.
Further improve the business layout, increase the company's market share and industry influence, improve and enhance the company's information management level, and ensure the sustainable and rapid development of the company's business
.
In this regard, the industry believes that in the future, with the professional medical technical team, medical service ability and level, medical quality status, scientific research and teaching and other comprehensive capabilities, He's Ophthalmology is expected to replicate the tertiary eye health medical service model and expand its business to Nationwide, further enhance the company's market competitiveness and achieve leapfrog development of the company
.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyone
.
